Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid

Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.

3,110 public trials 619 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myeloid trial results

Completed

A Study That Switched Patients From Imatinib to Nilotinib and Then Was Followed by Treatment Cessation

NCT01744665

Conditions
Bone Marrow Diseases, CML, Chronic Disease, +11 more
Locations
  • University of Alabama Comprehensive Cancer Center University of Alabama (8) Birmingham, Alabama, United States
  • Banner MD Anderson Cancer Center Banner MD Anderson (2) Gilbert, Arizona, United States
  • Scottsdale Healthcare/TGen Clinical Research Service SC Scottsdale, Arizona, United States
  • Highlands Oncology Group Fayetteville, Arkansas, United States
View all 54 locations
View Trial Details
Completed

Study of MLN4924 Plus Azacitidine in Treatment-naive Participants With Acute Myelogenous Leukemia (AML) Who Are 60 Years or Older

NCT01814826

Conditions
Acute Myelogenous Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Stanford University Stanford, California, United States
  • Hospital Corporation of America-HealthOne, LLC Denver, Colorado, United States
  • Mayo Clinic - Jacksonville, FL Jacksonville, Florida, United States
View Trial Details
Completed

A Study To Evaluate PF-04449913 With Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

NCT01546038

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +7 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • UC San Diego Moores Cancer Center - Investigational Drug Services La Jolla, California, United States
View all 81 locations
View Trial Details
Completed

Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)

NCT01349049

Conditions
Acute Myeloid Leukemia, Disease Attributes, Hematologic Diseases, +9 more
Locations
  • UCSF Helen Diller Family Family Comprehensive Cancer Center San Francisco, California, United States
  • Northwestern University Chicago, Illinois, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

A Multiple Ascending Dose Study of MEDI7247 in Patients With Selected Relapsed/Refractory Hematological Malignancies

NCT03106428

Conditions
Acute Myeloid Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +22 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Denver, Colorado, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site Chicago, Illinois, United States
View all 14 locations
View Trial Details

Related conditions